All posts tagged
After a Rough Year, uniQure CMO discusses a Comeback
UniQure takes an axe to its Pipeline and Workforce in new R&D Strategy
Why are there only 8 cell and gene therapies on the EU Market?
uniQure hits another rough patch as CEO jumps ship
This Dutch Gene Therapy is on the shelf and seems to Work. But nobody is buying…
FDA shelves UniQure’s Glybera – will the Gene therapy once reach the US market?
Labiotech UG, All Rights Reserved -
Send this to friend